Top 5 Post-bariatric Surgery Apps for Primary Care
Maintaining a healthy lifestyle after bariatric surgery can prove difficult for patients, but these 5 apps can help both in and out of the clinical setting. (Source: ConsultantLive)
Source: ConsultantLive - June 26, 2019 Category: Internal Medicine Authors: Ted W. James, MD Tags: Technology Source Type: news
Top 5 Bariatric Surgery Apps for Primary Care
Maintaining a healthy lifestyle after bariatric surgery can prove difficult for patients, but these 5 apps can help both in and out of the clinical setting. (Source: ConsultantLive)
Source: ConsultantLive - June 26, 2019 Category: Internal Medicine Authors: Ted W. James, MD Tags: Technology Source Type: news
Novel Dual-mechanism Agent Acts on Diabetes, Metabolic Complications
ADA 2019 ICYMI: Tirzepatide, a GIP and GLP-1 receptor agonist, reduces A1c and BMI as well as biomarkers of metabolic dysfunction in type 2 diabetes patients. Four studies reviewed. (Source: ConsultantLive)
Source: ConsultantLive - June 26, 2019 Category: Internal Medicine Authors: Kenneth J. Bender, PharmD, MA Tags: Diabetes Type 2 Source Type: news
Dual-Mechanism Investigational Agent Acts on Diabetes and Metabolic Complications
Kenneth J Bender, PharmD, MA
An investigational agent with dual mechanisms of action demonstrated benefit on markers of both diabetes and non-alcoholic steatohepatitis (NASH), in studies presented at the American Diabetes Association (ADA) Scientific Sessions meeting in San Francisco, CA June 7-11. (Source: ConsultantLive)
Source: ConsultantLive - June 26, 2019 Category: Internal Medicine Tags: Diabetes Type 2 Source Type: news
First Oral GLP-1 Agonist Showcased while Approval Pending
ADA 2019 ICYMI: Safety and efficacy of oral semaglutide in patients with T2DM was demonstrated in results of 3 PIONEER program clinical trials. Highlights, here. (Source: ConsultantLive)
Source: ConsultantLive - June 26, 2019 Category: Internal Medicine Authors: Kenneth J. Bender, PharmD, MA Tags: Diabetes Diabetes Type 2 Source Type: news
Gabapentinoids used Off-label for Pain: Effective or Erroneous?
Off-label gabapentin and pregabalin prescribing for pain is widespread; the opioid crisis may be to blame. But does science support the trend? Find out with these 10 questions. (Source: ConsultantLive)
Source: ConsultantLive - June 21, 2019 Category: Internal Medicine Authors: Steven A. King, MD, MS Tags: Pain Source Type: news
Which Weight Loss Drug for this Complex Patient?
She is 35 y/o with a history of migraine, bipolar disorder, and hypertension. Years of structured diets and nutrition consult have failed. Which agent would you consider? (Source: ConsultantLive)
Source: ConsultantLive - June 20, 2019 Category: Internal Medicine Authors: Ted W. James, MD Tags: Gastrointestinal Disorders Source Type: news
Two Bariatric Surgery Patients with Odd Post-op Complaints
Vomiting, rash, and mental changes; numbness in the feet and stumbling. What ' s causing these odd symptoms after successful weight loss surgery? (Source: ConsultantLive)
Source: ConsultantLive - June 19, 2019 Category: Internal Medicine Authors: Ted W. James, MD Tags: Gastrointestinal Disorders Source Type: news
COPD Insights: 8 Studies in Brief
Consequences of a late COPD diagnosis, a blood test to stratify mortality risk, and 6 other new studies offer insights into improving care for COPD patients. (Source: ConsultantLive)
Source: ConsultantLive - June 19, 2019 Category: Internal Medicine Authors: Leo Robert Tags: COPD Management Source Type: news
2019 GOLD Guidelines for COPD: Update Quiz
The 2019 GOLD Guidelines make a new distinction in how to choose initial and subsequent COPD treatment. Do you know what that is? Answer and 4 more questions, here. (Source: ConsultantLive)
Source: ConsultantLive - June 19, 2019 Category: Internal Medicine Authors: Veronica Hackethal, MD Tags: COPD Management Source Type: news
Chronic Hepatitis C Virus Infection Tied to Parkinson Disease
Parkinson disease may join the list of extrahepatic complications associated with HCV infection, according to a new study in JAMA Neurology. (Source: ConsultantLive)
Source: ConsultantLive - June 17, 2019 Category: Internal Medicine Authors: Veronica Hackethal, MD Tags: Hepatitis C Infectious Disease Source Type: news
Antibiotic-resistant Tuberculosis Reversed by New Compound
Isoniazid resistance in TB may be prevented and even reversed by a small newly identified molecule called C10, according to a recent study. (Source: ConsultantLive)
Source: ConsultantLive - June 17, 2019 Category: Internal Medicine Authors: Veronica Hackethal, MD Tags: Hepatitis C Infectious Disease Source Type: news
Linagliptin Found Safe in T2DM Patients at High Cardiorenal Risk
ADA 2019--Linagliptin, the DPP-4 inhibitor, showed similar risk for first or recurrent CV events or hopspitalization vs placebo in T2DM patients with high cardiorenal risk in CARMELINA subanalysis. (Source: ConsultantLive)
Source: ConsultantLive - June 17, 2019 Category: Internal Medicine Authors: Kenneth J. Bender, PharmD, MA Tags: Cardiovascular Disease Diabetes Diabetes Type 2 Source Type: news
SGLT2 Inhibitor Reduces CV, Renal Events in Type 2 Diabetes
ADA 2019 —Dapagliflozin reduced CV death, hospitalization for HF, and progression of CKD among T2DM patients with a wide distribution of baselines CVD risk in DECLARE-TIMI 58. (Source: ConsultantLive)
Source: ConsultantLive - June 17, 2019 Category: Internal Medicine Authors: Kenneth Bender, PharmD, MA Tags: Cardiovascular Disease Diabetes Diabetes Type 2 Source Type: news
How to Help Patients Quit Smoking: 10 Questions for Primary Care
Take this quick 10-question quiz to find out what you can do to help your patients live tobacco-free. (Source: ConsultantLive)
Source: ConsultantLive - June 14, 2019 Category: Internal Medicine Authors: Leo Robert Source Type: news
